Immix Biopharma Inc.

NASDAQ: IMMX · Real-Time Price · USD
2.27
0.08 (3.65%)
At close: Aug 15, 2025, 3:59 PM
2.27
0.00%
After-hours: Aug 15, 2025, 04:27 PM EDT

Immix Biopharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-21.7M -15.6M -8.23M -24.38M
Depreciation & Amortization
115.39K 5.47K 2.13K 2.47K
Stock-Based Compensation
3.02M 2.57M 624.07K 218.98K
Other Working Capital
537.2K 111.84K -936.53K -284.97K
Other Non-Cash Items
n/a n/a n/a 118.16K
Deferred Income Tax
n/a n/a n/a 22.85M
Change in Working Capital
3.97M 1.65M 195.21K -391.04K
Operating Cash Flow
-14.6M -11.37M -7.41M -1.59M
Capital Expenditures
-1.18M -52.09K n/a -802
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-1.18M -52.09K n/a -802
Debt Repayment
n/a n/a -50K 200K
Common Stock Repurchased
n/a n/a -99.96K n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
2.49K -232K 468.28K n/a
Financial Cash Flow
15.95M 15.46M 3.23M 18.85M
Net Cash Flow
172.17K 4.07M -4.21M 17.25M
Free Cash Flow
-15.77M -11.42M -7.41M -1.59M